Watchlist Price Alert

Rein Therapeutics Inc. (RNTX)

NASDAQ: RNTX · Real-Time Price · USD

2.00

0.05 (2.56%)

At close: Jun 06, 2025, 3:52 PM

2.05

2.50%

After-hours: Jun 06, 2025, 04:17 PM EDT

Rein Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	12.87M	17.31M	5.19M	3.6M	7.05M	5.31M	10.63M	11.86M	20.71M
Short-Term Investments	n/a	n/a	16.05M	42.33M	6.76M	12.97M	10.06M	38.89M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	2K	2.19M	24K	24K	n/a	568K	1.25M	694K	841K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	676K	746K	631K	25K	593K	25K	25K	88K	25K
Total Current Assets	13.66M	18.27M	21.87M	48.18M	16.33M	19.55M	21.77M	51.84M	21.07M
Property-Plant & Equipment	1K	19K	110K	280K	15K	6.36M	7.29M	154K	107K
Goodwill & Intangibles	48.53M	85.53M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	48.53M	87.74M	134K	304K	15K	6.92M	8.54M	848K	948K
Total Assets	62.19M	106.01M	22.01M	48.48M	16.34M	26.47M	30.31M	52.69M	22.02M
Account Payables	911K	1.19M	1.72M	1.21M	1.6M	1.45M	1.73M	1.6M	1.97M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	168K	n/a	n/a	n/a	n/a
Other Current Liabilities	122K	206K	181K	60K	243K	352K	423K	351K	1.05M
Total Current Liabilities	5.75M	4.38M	3.38M	4.51M	3.96M	5.84M	5.37M	4.89M	4.07M
Long-Term Debt	n/a	n/a	n/a	n/a	219K	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	45.28M	91.41M	n/a	n/a	n/a	n/a	n/a	n/a	129.76M
Total Long-Term Liabilities	47.05M	94.74M	n/a	69K	219K	4.59M	5.34M	n/a	129.76M
Total Liabilities	7.8M	99.12M	3.38M	4.58M	4.18M	10.43M	10.71M	4.89M	133.83M
Total Debt	n/a	48K	33K	162K	387K	5.03M	5.34M	n/a	n/a
Common Stock	108K	91K	91K	91K	44K	28K	15K	15K	n/a
Retained Earnings	-351.4M	-288.52M	-272.79M	-245.46M	-219.29M	-198.13M	-168.49M	-136.95M	-114.34M
Comprehensive Income	-18K	-63K	-48K	-13K	-2K	7K	-5K	-33K	n/a
Shareholders Equity	54.39M	6.89M	18.62M	43.9M	12.16M	16.05M	19.6M	47.8M	-111.81M
Total Investments	n/a	n/a	16.05M	42.33M	6.76M	12.97M	10.06M	38.89M	n/a